StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Basilea Pharmaceutica AG
Swiss Stock Exchange:BSLN.SW
Sector
Industries
Location
Market Cap
USD 841.80 M
Share Price
USD 68.63
Avg Daily Volume
37,009
Change (1 day)
1.01%
Change (1 year)
55.97%
Change (YTD)
50.11%
Basilea Pharmaceutica AG Enterprise Value to EBITDA (EV/EBITDA) on July 23, 2025: 11.97
Basilea Pharmaceutica AG Enterprise Value to EBITDA (EV/EBITDA) is 11.97 on July 23, 2025, a -46.09% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Basilea Pharmaceutica AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 27.74 on July 23, 2025, which is 131.78% above the current Enterprise Value to EBITDA (EV/EBITDA).
-
Basilea Pharmaceutica AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 7.99 on July 23, 2025, which is -33.27% below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Basilea Pharmaceutica AG average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 19.50.
Competitors
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Vertex Pharmaceuticals Incorporated
USD 476.95
VRTX
+6.82
1.45%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
CSL Limited
USD 178.31
CSL.AX
+3.04
1.74%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%
MERCK Kommanditgesellschaft auf Aktien
USD 132.14
MRK.DE
+4.08
3.19%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.97
600276.SS
-0.01
-0.09%
Takeda Pharmaceutical Company Limited
USD 29.83
4502.T
+0.18
0.60%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Vertex Pharmaceuticals Incorporated
USD 476.95
VRTX
+6.82
1.45%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
CSL Limited
USD 178.31
CSL.AX
+3.04
1.74%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%
MERCK Kommanditgesellschaft auf Aktien
USD 132.14
MRK.DE
+4.08
3.19%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.97
600276.SS
-0.01
-0.09%
Takeda Pharmaceutical Company Limited
USD 29.83
4502.T
+0.18
0.60%